Acadia Pharmaceuticals | ACAD - Créances Commerciales





Créances Commerciales Changement Date
Acadia Pharmaceuticals USD 148.38M 153K 2026-03
ALKERMES USD 407.63M 73.6M 2026-03
Alnylam Pharmaceuticals USD 883.96M 106.39M 2026-03
Biogen USD 1.79B 76.6M 2026-03
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
Bristol-Myers Squibb USD 14.36B 164M 2026-03
Cara Therapeutics USD 2.24M 2.26M 2025-03
Corcept Therapeutics USD 39.07M 20.71M 2026-03
Cytokinetics USD 6.83M 10.94M 2026-03
Eisai JPY 227B 22.05B 2026-03
Eli Lilly USD 21.18B 1.02B 2026-03
Incyte USD 1.05B 27.09M 2026-03
J&J USD 22.54B 1.21B 2026-03
Moderna USD 71M 113M 2026-03
Neurocrine Biosciences USD 768.1M 81.3M 2026-03
Pfizer USD 16.17B 332M 2026-03
Prothena USD 5.16M 0 2023-12
PTC Therapeutics USD 181.62M 21.45M 2025-12
Sarepta Therapeutics USD 547.91M 149.68M 2026-03
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12
Vertex Pharmaceuticals USD 2B 56.7M 2026-03